Gynaecological Follow-up of Women With Down Syndrom Aged 18 to 30 in France
NCT ID: NCT06117228
Last Updated: 2023-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2023-12-01
2024-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In France, there are one million people with an intellectual disability, including 50,000 with Down syndrome.
Although this disability causes numerous physical and psychological deficits, no gynaecological consequences have yet been demonstrated.
Regular gynaecological check-ups are therefore necessary, according to French recommendations.
However, several studies have shown that women with mental illness receive less or no gynaecological care.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Qualitative Exploratory Study Among Reunionese Women and Their Partners Who Have a Child With Trisomy 21
NCT04811534
Developing a Down Syndrome Health Instrument
NCT04631237
Factors Associated With Gynecological Consultation by General Practitioner
NCT05578924
145/5000 Oral State and Knowledge, Attitudes and Practices of Pregnant Women on Their Oral Health and That of Their Unborn Child
NCT04269759
Role of Parents Concerning Information of Adolescents About Contraception
NCT05647603
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
women with Down syndrome aged 18 to 30
women aged 18 to 30 with Down syndrome, whether or not they were receiving medical care, who agreed to take part in the study.
Data collection
Data collection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data collection
Data collection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged between 18 and 30,
* whether or not they are being followed up in a medical facility,
* who agree to take part in the study.
Exclusion Criteria
* Not agreeing to take part in the study
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université de Reims Champagne-Ardenne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Muller Gaëlle
Role: PRINCIPAL_INVESTIGATOR
Université de Reims Champagne-Ardenne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ufr Medecine Urca
Reims, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023_RIPH_016_Gyn-T21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.